The Boston Psychedelic Research Group is a Massachusetts nonprofit corporation committed to the promotion,
dissemination, and advancement of psychedelic research. We are a hub for education about the powerful benefits psychedelic-assisted therapy can have in the treatment of a wide variety of mental health issues. We do this primarily by holding bimonthly meetings where attendees can gather and converse, hear a prominent speaker share his or her work, and participate in a Q&A session.
Based in Cambridge, Massachusetts, the BPRG started in 2018 over an informal lunch. Years later we have over 300 members and are growing both in Boston and globally.
our BOARD OF DIRECTORS:
Anne St. Goar
After training at Harvard and Massachusetts General Hospital in Internal Medicine, Anne was a primary care physician in the Boston area at Harvard Vanguard Medical Associates for more than 30 years. During her last 10 years of practice, she realized how much PTSD affected so many people, both physically and emotionally. In exploring treatments for PTSD, she discovered the work the Multidisciplinary Association for Psychedelic Studies (MAPS) is doing with MDMA-assisted psychotherapy and decided to get involved. In 2016, Anne became a certified Psychedelic Therapist and Researcher through the California Institute of Integral Studies (CIIS). Anne is currently a Phase 3 therapist for the MAPS study in Boston. She lives in Cambridge with her husband, with whom she has three grown children, three children-in-law, and three grandchildren.
Dick Simon is an entrepreneur, social enterprise philanthropist, and catalyst for change. After September 11, 2001, Dick left the for-profit world to co-found and chair the YPO Peace Action Network (PAN), which lever-ages personal and business relationships, resources, and expertise for conflict resolution on local and global levels. Dick's work has earned him YPO’s Global Humanitarian Award, Harvard Business School's Making a Difference Award, a place in Real Leaders magazine's list of "100 Visionary Leaders," and other honors. Dick has been supporting the work of organizations pursuing FDA and EMA clinical trials of psychedelics as treatments for mental health issues. He is working to shift public perception of these medicines and working with researchers studying psychedelic treatments for a wide range of indications as well as their possible use in conflict resolution.
Ron strongly supports research into the safe and therapeutic use of psychedelic medicines to treat depression, PTSD, addictions and other behavioral disorders. Ron co-founded with Anne and Dick the Boston Psychedelic Research Group, and completed the year-long certification program in Psychedelic Therapies and Research at the California Institute for Integral Studies. He is also a co-founder of Sunstone Therapies LLC, an organization dedicated to improving cancer patient experiences and outcomes from psychedelic therapy. Ron is an Advisor to the Center for the Neuroscience of Psychedelics at the Massachusetts General Hospital and seeks to support other new and growing organizations that conduct research into the therapeutic use of psychedelic medicines. Ron graduated from Yale College and the Harvard Business School. He manages a private investment fund and lives with his girlfriend Giorgi and their adorable dog Arlo in Weston, Massachusetts.